Regulacje i polityka gospodarcza · 10/10/2000

NIH Seeks Licensee for Chromatin Insulator Technology for Human Gene Therapy or Mammalian Transgenic Systems

The National Institutes of Health is seeking a licensee to develop the chromatin insulator technology, which protects expressed genes of interest for human gene therapy or other mammalian transgenic systems, and has assigned patent rights to the United States of America.